LRA-Funded Researchers Share Important Discoveries at Largest Rheumatology Meeting
November 19, 2020 The Lupus Research Alliance supported an impressive number — 30+ — of studies presented at ACR Convergence 2020, this year’s meeting of the American College of Rheumatology. Each year, researchers are selected to share their discoveries in talks and poster sessions, allowing medical professionals to keep up to date with the latest […]
Summary Highlights of Important Research Presented at ACR Convergence 2023
At the recent ACR Convergence 2023, the annual meeting of the American College of Rheumatology, important lupus clinical trial data and breakthrough foundational research were presented. Following are highlights of work funded by the Lupus Research Alliance or supported in partnership with industry through our clinical affiliate Lupus Therapeutics. CAR-T Cell Therapy is Showing Great […]
Lupus Industry Council Accomplishments
Return to Research Partners Drivers of Response and Non-response for SRI-4 and BICLA in Systemic Lupus Erythematosus (SLE) Clinical Trials Working Group Chair: Matthew Linnik (Eli Lilly) The paucity of success in late-stage clinical trials in systemic lupus erythematosus (SLE) remains a persistent and challenging problem with one of the key issues being the primary […]
Proliferative Lupus Nephritis
Inflammation of the kidneys caused by an autoimmune disease called systemic lupus erythematosus. The condition can cause hematuria and proteinuria, and it may progress to end-stage renal disease. The most severe form of lupus nephritis, called diffuse proliferative nephritis, can cause scars to form in the kidneys. Scars are permanent, and kidney function often declines […]
Dr. William E. Paul Distinguished Innovator Award (DIA)
The Dr. William E. Paul Distinguished Innovator Award ($1M over 4 years) provides outstanding scientists with substantial support to conduct novel research into the fundamental causes of systemic lupus erythematosus. If you are a researcher and would like to learn more about our funded research please click here.
LRA-Funded Researchers Presented Cutting Edge Methods and Discoveries at the Annual Rheumatology Meeting
November, 2022 The Lupus Research Alliance (LRA) aims to support the best science to prevent, treat and cure lupus. This year during the annual American College of Rheumatology conference, ACR Convergence 2022, which took place from November 10 – 14 in Philadelphia, PA, more than 30 LRA-funded studies were presented by researchers to thousands of […]
Scientific Advisory Board
3 Questions with Dr. Ashira Blazer
March 8, 2023 As part of our researcher interview series, we are featuring 3 Questions with Ashira Blazer, MD, at Hospital for Special Surgery — one of our Diversity in Lupus Research Award recipients. Below Dr. Blazer explains why she focused her career on lupus, and explains how the project LRA is funding will help […]
LRA Researchers Reveal New Drug Targets at Leading Immunology Conference
May 22, 2019 Data presented by several Lupus Research Alliance-funded scientists at the recent American Association of Immunologists Annual Meeting suggests many avenues for new lupus treatments. Some scientists presented data posing new targets for drug development, while others have discovered cells that suppress the immune response and could be harnessed as treatments. Reining in […]
New LRA-Supported Study Discovers STAT1, a Highly Specific Target for Potential New Therapy
April 23, 2020 A new study supported by the Lupus Research Alliance discovered a way that harmful immune responses in lupus and lupus nephritis could be stopped while protective immune responses, such as those to infection, are preserved. The findings were published in the prestigious Journal of Immunology and add evidence to the value of […]
LRA-Funded Scientists Command Attention at 2019 ACR/ARP
November 14, 2019 The Lupus Research Alliance was proud of the unprecedented number of the studies supported by the Alliance chosen for presentation at the 2019 ACR/ARP Annual Meeting, the world’s largest rheumatology conference. A total of 19 studies were shared in oral presentations to large audiences, while 13 were presented as posters, which allow […]
Promising Results from AMP
October 30, 2018 The Lupus Research Alliance is one of the sponsors of the Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus (AMP RA/Lupus), a public-private partnership between the National Institutes of Health, the U.S. Food and Drug Administration and several pharmaceutical companies and nonprofit organizations. AMP aims to speed the development of new therapies, […]